| Otolaryngology |
1 |
1 |
| Noncolorectal Gastrointestinal Cancer |
0 |
0.9 |
| Esophageal Cancer |
0 |
0.99 |
| COVID-19 |
0 |
0.62 |
| Chemotherapy |
0 |
0.6 |
| Cancer |
0 |
0.52 |
| Biologic Therapy |
0 |
0.43 |
| Esophagus |
0 |
0.43 |
| Squamous Cell Carcinoma |
0 |
0.98 |
| Toxicology |
0 |
0.43 |
| Acute Pain |
0 |
0.34 |
| Cancer Pain |
0 |
0.3 |
| Aminotransferase |
0 |
0.17 |
| Adenocarcinoma of the Gastroesophageal Junction |
0 |
0.12 |
| Pain Management |
0 |
0.1 |
| Adenocarcinoma |
0 |
0.09 |
| Anemia |
0 |
0.09 |
| California |
0 |
0.09 |
| Cough |
0 |
0.09 |
| Europe |
0 |
0.09 |
| Fatigue |
0 |
0.09 |
| Food and Drug Administration (FDA) |
0 |
0.09 |
| Hemoglobin |
0 |
0.09 |
| Immunoglobulin A (IgA) |
0 |
0.09 |
| Intravenous |
0 |
0.09 |
| Lymphocytes |
0 |
0.09 |
| Monoclonal Antibody |
0 |
0.09 |
| Pain |
0 |
0.09 |